Lejeune et al. BMC Genomics 2012, 13:91 http://www.biomedcentral.com/1471-2164/13/91 25. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28(1):27-30. 26. Lee I, Lehner B, Crombie C, Wong W, Fraser AG, Marcotte EM: A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans. Nat Genet 2008, 40(2):181-188. 27. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, Vidalain PO, Han JD, Chesneau A, Hao T, et al: A map of the interactome network of the metazoan C. elegans. Science 2004, 303(5657):540-543. 28. Chen N, Harris TW, Antoshechkin I, Bastiani C, Bieri T, Blasiar D, Bradnam K, Canaran P, Chan J, Chen CK, et al: WormBase: a comprehensive data resource for Caenorhabditis biology and genomics. Nucleic Acids Res 2005, , 33 Database issue: D383-D389. 29. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, et al: Towards a proteome- scale map of the human protein-protein interaction network. Nature 2005, 437(7062):1173-1178. 30. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE, Godwin B, Vitols E, et al: A protein interaction map of Drosophila melanogaster. Science 2003, 302(5651):1727-1736. 31. Lee I, Li Z, Marcotte EM: An improved, bias-reduced probabilistic functional gene network of baker’s yeast, Saccharomyces cerevisiae. PLoS One 2007, 2(10):e988. 32. Rapaport F, Zinovyev A, Dutreix M, Barillot E, Vert JP: Classification of microarray data using gene networks. BMC Bioinforma 2007, 8:35. 33. Russ AP, Lampel S: The druggable genome: an update. Drug Discov Today 2005, 10(23-24):1607-1610. 34. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, et al: A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122(6):957-968. 35. Remm M, Storm CE, Sonnhammer EL: Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J Mol Biol 2001, 314(5):1041-1052. 36. Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, Huyck M, DeLisi C: VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res 2009, , 37 Web Server: W115-W121. 37. Calixto A, Chelur D, Topalidou I, Chen X, Chalfie M: Enhanced neuronal RNAi in C. elegans using SID-1. Nat Methods 2010, 7(7):554-559. 38. Doumanis J, Wada K, Kino Y, Moore AW, Nukina N: RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS One 2009, 4(9):e7275. 39. Zhang S, Binari R, Zhou R, Perrimon N: A genome-wide RNAi screen for modifiers of aggregates formation by mutant huntingtin in Drosophila. Genetics 2010, 184(4):1165-1179. 40. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI, Plasterk RH: Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci USA 2004, 101(17):6403-6408. 41. Silva MC, Fox S, Beam M, Thakkar H, Amaral MD, Morimoto RI: A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet 2011, 7(12):e1002438. 42. Jin K, LaFevre-Bernt M, Sun Y, Chen S, Gafni J, Crippen D, Logvinova A, Ross CA, Greenberg DA, Ellerby LM: FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci USA 2005, 102(50):18189-18194. 43. Lievens JC, Rival T, Iche M, Chneiweiss H, Birman S: Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet 2005, 14(5):713-724. 44. Nguyen MD, Julien JP, Rivest S: Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002, 3(3):216-227. 45. Kruer MC, Hiken M, Gregory A, Malandrini A, Clark D, Hogarth P, Grafe M, Hayflick SJ, Woltjer RL: Novel histopathologic findings in molecularly- confirmed pantothenate kinase-associated neurodegeneration. Brain 2011, 134(Pt 4):947-958. 46. Gines S, Ivanova E, Seong IS, Saura CA, MacDonald ME: Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D- aspartate receptor activation in Huntington’s disease knock-in striatal cells. J Biol Chem 2003, 278(50):50514-50522. 47. Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J, Andrews-Zwilling Y, Hsieh EW, et al: Kynurenine 3- Page 14 of 14 monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 2011, 145(6):863-874. 48. Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ: Neurological abnormalities in a knock-in mouse model of Huntington’s disease. Hum Mol Genet 2001, 10(2):137-144. 49. Raymond LA, Andre VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS: Pathophysiology of Huntington’s disease: time-dependent alterations in synaptic and receptor function. Neuroscience 2011, 198:252-273. 50. Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL: Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci USA 2005, 102(8):2725-2730. 51. Hageman J, van Waarde MA, Zylicz A, Walerych D, Kampinga HH: The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem J 2011, 435(1):127-142. 52. Ables JL, Breunig JJ, Eisch AJ, Rakic P: Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci 2011, 12(5):269-283. 53. Perrin V, Dufour N, Raoul C, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Deglon N: Implication of the JNK pathway in a rat model of Huntington’s disease. Exp Neurol 2009, 215(1):191-200. doi:10.1186/1471-2164-13-91 Cite this article as: Lejeune et al.: Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons. BMC Genomics 2012 13:91. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit